Pernicious anemia is diagnosed by checking for vitamin B12 deficiency and looking for evidence that the body cannot absorb B12 because of an autoimmune problem. In older adults, clinicians usually review symptoms and medical history, order blood tests, and may test for antibodies against intrinsic factor, a protein needed to absorb B12. A negative antibody test does not always rule it out.
Why can pernicious anemia be difficult to recognize in older adults?
Pernicious anemia is a condition in which the immune system interferes with the stomach's ability to support vitamin B12 absorption. The stomach normally produces a protein called intrinsic factor, which helps the body absorb vitamin B12 from food. When an autoimmune process damages the cells involved in this process, vitamin B12 levels can fall and eventually affect red blood cell production and nerve function.
Diagnosis can be challenging in older adults because possible symptoms may develop gradually and overlap with other health conditions. Tiredness, reduced stamina, concentration difficulties, or changes in balance may have several explanations. A person may also have vitamin B12 deficiency without the typical blood changes associated with anemia.
According to the National Institute for Health and Care Excellence (NICE), vitamin B12 deficiency should not be ruled out solely because anemia or enlarged red blood cells are absent. This is particularly important when an older adult has unexplained neurological symptoms or other findings that raise concern about a deficiency.
What symptoms and medical history may lead to testing?
A healthcare professional considers the person's experiences alongside their medical history, examination findings, medicines, diet, and previous laboratory results. Symptoms alone cannot distinguish pernicious anemia from other causes of vitamin B12 deficiency or other medical conditions.
Experiences that may prompt further evaluation include:
- Persistent tiredness, weakness, or reduced ability to manage usual activities.
- Unexplained breathlessness or a racing heartbeat that may be associated with anemia.
- A sore or unusually smooth tongue, or other changes affecting the mouth.
- Tingling or numbness in the hands or feet.
- Changes in walking, balance, memory, concentration, or other aspects of nerve function.
The UK National Health Service (NHS) explains that symptoms and blood test results are considered together when investigating vitamin B12 deficiency. A clinician may also ask about previous stomach surgery, digestive conditions, restricted food intake, and medicines that can affect vitamin B12 levels or absorption.
Which blood tests are used to diagnose pernicious anemia?
1. Complete blood count
A complete blood count (CBC) measures blood components, including hemoglobin and red blood cells. It helps clinicians determine whether anemia is present and whether the red blood cells are larger than expected. Vitamin B12 deficiency can cause a pattern of enlarged red blood cells, but this finding is not specific to pernicious anemia.
The CBC provides useful clues rather than identifying the cause on its own. Other conditions, including folate deficiency and certain bone marrow disorders, can also affect red blood cell size. Some people with vitamin B12 deficiency have a CBC that does not show the expected changes, so additional testing may still be appropriate.
2. Vitamin B12 and folate blood tests
A blood test for total vitamin B12 is commonly used as an initial investigation. In some circumstances, a clinician may choose an active vitamin B12 test, which measures the portion of the vitamin available to cells. Folate may also be measured because folate deficiency can cause similar blood changes.
Results are interpreted using the laboratory's reference information and the person's clinical circumstances. A result near a laboratory's decision threshold may need further evaluation, particularly if the person's symptoms or examination findings suggest a deficiency. Vitamin B12 supplements and recent injections can also affect test results, so the clinician should know about any supplements or treatment already being taken.
3. Methylmalonic acid and homocysteine
If the initial vitamin B12 result is unclear, a clinician may request another blood test to help determine whether the body has enough usable vitamin B12. One option is methylmalonic acid (MMA). Homocysteine is another possible test, although its result can also be affected by folate status and other factors.
Kidney function is especially relevant when interpreting MMA in older adults. Reduced kidney function can raise MMA levels independently of vitamin B12 deficiency, so a raised result must be considered alongside kidney-related findings, vitamin B12 measurements, symptoms, and other evidence. These additional tests help assess the possibility of deficiency but do not, by themselves, establish pernicious anemia as the cause.
How do doctors confirm that vitamin B12 deficiency is caused by pernicious anemia?
Once vitamin B12 deficiency is suspected or established, the next step is to investigate why it has occurred. Pernicious anemia is associated with an autoimmune problem affecting vitamin B12 absorption. Other explanations for low vitamin B12 include inadequate dietary intake, certain digestive conditions, previous gastrointestinal surgery, and medication-related effects. Identifying the cause helps guide ongoing care.
Intrinsic factor antibody test
The intrinsic factor antibody test looks for antibodies directed against intrinsic factor, the protein needed for normal vitamin B12 absorption. A positive result strongly supports pernicious anemia when the other findings fit. However, not everyone with the condition has detectable intrinsic factor antibodies.
Mayo Clinic Laboratories notes that a positive intrinsic factor blocking antibody result strongly supports pernicious anemia, while a negative or inconclusive result does not exclude it. This limitation matters when an older adult has convincing evidence of vitamin B12 deficiency but the antibody test is negative.
Parietal cell antibodies and other investigations
If intrinsic factor antibodies are absent but autoimmune gastritis remains a concern, a clinician may consider testing for antibodies against gastric parietal cells. These are cells in the stomach lining involved in producing substances needed for digestion and vitamin B12 absorption. Parietal cell antibodies can provide additional evidence, but they are less specific and are not sufficient on their own to confirm pernicious anemia.
Depending on the clinical picture, further investigations may include a gastrin blood test, which can provide information about stomach function, or a specialist procedure called gastroscopy with a biopsy of the stomach lining. A biopsy allows the specialist to examine tissue for changes associated with autoimmune gastritis. These investigations are not necessary for every person; they may be considered when the initial results do not resolve the cause.
The NICE vitamin B12 deficiency guideline describes these additional options when autoimmune gastritis is suspected despite a negative intrinsic factor antibody test. The choice depends on the findings already available, the person's circumstances, and the investigations appropriate to their case.
What is different about the diagnostic process in older adults?
There is no single age-specific blood test that confirms pernicious anemia. The same core approach is used in older and younger adults, but clinicians may need to consider more possible explanations for an abnormal result. Other illnesses, changes in nutrition, multiple medicines, and reduced kidney function may affect how symptoms and laboratory tests are interpreted.
For example, an older adult with fatigue and anemia may need evaluation for causes other than vitamin B12 deficiency. Similarly, memory changes or difficulty walking should not automatically be attributed to aging. If there are findings that could fit vitamin B12 deficiency, they may justify testing even when a CBC does not show anemia.
According to the Merck Manual Professional Edition, neurological problems associated with vitamin B12 deficiency can occur before anemia becomes apparent or even when anemia is absent. Prompt assessment is therefore important when new or worsening tingling, numbness, walking difficulties, or balance problems are present.
How should test results be understood?
No single result should be interpreted in isolation. Clinicians compare the blood count, vitamin B12 measurements, any additional biochemical tests, antibody results, and the person's history to determine whether the available evidence supports pernicious anemia or points to another explanation.
Several patterns can occur during an investigation:
- Low vitamin B12 with positive intrinsic factor antibodies: This combination supports vitamin B12 deficiency caused by pernicious anemia, when the clinical findings are consistent.
- Low vitamin B12 with negative intrinsic factor antibodies: Pernicious anemia may still be present. Other evidence or additional investigations may be needed.
- An unclear vitamin B12 result with ongoing concern: The clinician may consider MMA, homocysteine, or other tests, depending on the findings and possible factors affecting the results.
- Evidence of anemia without clear vitamin B12 deficiency: Other possible causes need to be considered rather than assuming pernicious anemia.
Laboratory reference ranges and decision limits can differ between laboratories. Results should therefore be interpreted using the reporting laboratory's guidance and the person's overall clinical picture, rather than by applying a single numerical cutoff without context.
What happens after a diagnosis is established?
Confirming the underlying cause helps determine how vitamin B12 deficiency should be managed and whether replacement will be needed over the long term. When pernicious anemia is caused by an ongoing problem with absorption, vitamin B12 replacement is generally required indefinitely. The clinician will decide on the appropriate route and schedule of replacement based on the cause, symptoms, and clinical circumstances.
Follow-up may include repeat blood tests and a review of symptoms to assess the response to treatment. If neurological symptoms are present, their progress also needs attention. New or worsening symptoms may prompt reassessment of the diagnosis, treatment approach, or other possible causes.
Older adults with persistent unexplained fatigue, changes in sensation, or new difficulties with balance or walking should arrange a medical assessment. Prompt evaluation is particularly important when neurological symptoms are developing, because prolonged vitamin B12 deficiency can sometimes lead to lasting nerve problems.